| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Obstetrics and Gynecology,*the First Department of Internal Medicine, School of Medicine, and the Department of Molecular Biology,¶Cancer Research Institute, Kanazawa University, Kanazawa; New Business and Licensing Department, Kyowa Medex Company, Limited, Tokyo; the Department of Molecular Pathology, The Research Institute of Tuberculosis, Tokyo; and the Department of Molecular Biology,|| Graduate School of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan
Human telomerase reverse transcriptase (hTERT) is a catalytic subunit of telomerase and is a potentially useful diagnostic marker for cancers. There have been few studies in which immunological detection of hTERT has been attempted and its subcellular localization has not been precisely defined. In the present study, we re-evaluated expression and localization of hTERT in cancer and normal cells using a newly developed antibody. Immunohistochemistry revealed that hTERT is expressed in 
80% of gynecological cancers, but some premalignant lesions exhibited weak expression of hTERT. Interestingly, not only nuclei but also cytoplasm of cancer cells were positive for hTERT staining. This finding was supported by the results of Western blot analysis of cell lines, in which both nuclear and cytoplasmic extracts exhibited significant hTERT bands. Cytoplasmic hTERT in cancer cells may be functional because the telomeric repeat amplification protocol assay of cytoplasmic extracts showed high levels of telomerase activity. Unexpectedly, not all normal primary cells and telomerase-negative cancer cell lines lacked hTERT expression; some exhibited weak TERT signals. In Western analysis, hTERT signals did not always correlate with telomerase activity of the various cell types. These findings suggest that functional hTERT is expressed in both the nucleus and cytoplasm of cancer cells and that hTERT expression does not strictly reflect telomerase activity. Further analysis is needed to clarify the biological significance of cytoplasmic hTERT.
This article has been cited by other articles:
 |
|
 |
|
  D. Moretti, B. Del Bello, E. Cosci, M. Biagioli, C. Miracco, and E. Maellaro Novel variants of muscle calpain 3 identified in human melanoma cells: cisplatin-induced changes in vitro and differential expression in melanocytic lesions Carcinogenesis, June 1, 2009; 30(6): 960 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Fusaro, S. Panarese, B. Brunetti, D. Zambelli, C. Benazzi, and G. Sarli Quantitative analysis of telomerase in feline mammary tissues J Vet Diagn Invest, May 1, 2009; 21(3): 369 - 373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Miyoshi, S. Hirohata, H. Ogawa, M. Doi, M. Obika, T. Yonezawa, Y. Sado, S. Kusachi, S. Kyo, S. Kondo, et al. Tumor-specific expression of the RGD-{alpha}3(IV)NC1 domain suppresses endothelial tube formation and tumor growth in mice FASEB J, September 1, 2006; 20(11): 1904 - 1906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Higashi, S. Kyo, M. Inoue, H. Tanii, and K. Saijoh Novel Functional Single Nucleotide Polymorphisms in the Latent Transforming Growth Factor-{beta} Binding Protein-1L Promoter: Effect on Latent Transforming Growth Factor-{beta} Binding Protein-1L Expression Level and Possible Prognostic Significance in Ovarian Cancer J. Mol. Diagn., July 1, 2006; 8(3): 342 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Bravaccini, M A Sanchini, A Amadori, L Medri, L Saragoni, D Calistri, F Monti, A Volpi, and D Amadori Potential of telomerase expression and activity in cervical specimens as a diagnostic tool J. Clin. Pathol., September 1, 2005; 58(9): 911 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B Luzar, M Poljak, A Cor, U Klopcic, and V Ferlan-Marolt Expression of human telomerase catalytic protein in gallbladder carcinogenesis J. Clin. Pathol., August 1, 2005; 58(8): 820 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Tentori, O. Forini, E. Fossile, A. Muzi, M. Vergati, I. Portarena, C. Amici, B. Gold, and G. Graziani N3-Methyladenine Induces Early Poly(ADP-Ribosylation), Reduction of Nuclear Factor-{kappa}B DNA Binding Ability, and Nuclear Up-Regulation of Telomerase Activity Mol. Pharmacol., February 1, 2005; 67(2): 572 - 581. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
